Daphne Karydas

Director

Director at Mineralys Therapeutics, Inc., filing insider transactions between 2026-03-31 and 2026-06-17.

Total Purchases

—

0 transactions

Total Sales

$150K

2 transactions

Companies Traded

1

2 total filings

Active Since

2026-03-31

Last: 2026-06-17

Companies

Mineralys Therapeutics, Inc.

Other Reporting Insiders at Mineralys Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-17	MLYS	Sale	3,000	$25.00	$75K	6,200	SEC ↗
2026-03-31	MLYS	Sale	3,000	$25.00	$75K	6,200	SEC ↗

Daphne Karydas (Mineralys Therapeutics, Inc.) Insider Trades | Tormere